Department of Cardiology, Thorax Center, Erasmus University Medical Center, 3015GD Rotterdam, The Netherlands.
Sensors (Basel). 2023 Jan 26;23(3):1364. doi: 10.3390/s23031364.
Chronic heart failure (HF) is associated with high hospital admission rates and has an enormous burden on hospital resources worldwide. Ideally, detection of worsening HF in an early phase would allow physicians to intervene timely and proactively in order to prevent HF-related hospitalizations, a concept better known as remote hemodynamic monitoring. After years of research, remote monitoring of pulmonary artery pressures (PAP) has emerged as the most successful technique for ambulatory hemodynamic monitoring in HF patients to date. Currently, the CardioMEMS and Cordella HF systems have been tested for pulmonary artery pressure monitoring and the body of evidence has been growing rapidly over the past years. However, several ongoing studies are aiming to fill the gap in evidence that is still very clinically relevant, especially for the European setting. In this comprehensive review, we provide an overview of all available evidence for PAP monitoring as well as a detailed discussion of currently ongoing studies and future perspectives for this promising technique that is likely to impact HF care worldwide.
慢性心力衰竭（HF）与高住院率相关，在全球范围内给医院资源带来了巨大负担。理想情况下，早期发现 HF 恶化将使医生能够及时主动地进行干预，以预防 HF 相关的住院治疗，这一概念通常被称为远程血液动力学监测。经过多年的研究，肺动脉压力（PAP）的远程监测已成为 HF 患者迄今为止最成功的动态血液动力学监测技术。目前，CardioMEMS 和 Cordella HF 系统已经过肺动脉压力监测的测试，近年来，相关证据迅速增加。然而，目前仍有多项正在进行的研究旨在填补仍具有重要临床意义的证据空白，尤其是对于欧洲环境而言。在本综述中，我们全面概述了 PAP 监测的所有现有证据，并详细讨论了目前正在进行的研究和未来展望，这项很有前景的技术有望影响全球 HF 的治疗。
